Skip to main content
. 2019 Oct 3;47(3):264–271. doi: 10.1159/000503012

Table 2.

Published case reports of HDFN caused by anti-Rh17 alloimmunization: outcome and transfusion therapy of HDFN

Case Authors [reference], year of publication Order of pregnancies HDFN and outcome Transfusion therapy and other management of HDFN Source of RBC for fetal and neonatal transfusion
1 De Torregrosa et al. [5], 1961 First Neonatal jaundice at age 24 h, at the fourth day clinical presentation of neonatal generalized edema and poor general condition; ET was late and neonate died toward the end of the procedure 1 ET after 4 days Maternal RBCs

Second Stillborn fetus in 7th month of pregnancy

2 Badakere and Bhatia [6], 1973 Fifth Neonatal death within the first 24 h 1 ET (180 mL) Maternal RBCs

Sixth Neonatal death within the first 24 h 1 ET (180 mL) Maternal RBCs

3 Diao et al. [7], 1990 Third CS at 36th week of pregnancy; severe anemia and hyperbilirubinemia; after therapy baby is alive and in good health 1 ET, 1 TUT Incompatible RBCs phenotype ccDEE

4 Mertens et al. [8], 1997 Second CS in 39th week of pregnancy, severe neonatal anemia and hyperbilirubinemia; after therapy the infant is alive and in good health 1 ET Compatible thawed RBC (Bank of Frozen Blood)

5 Han et al. [9], 1997 Third CS, severe anemia (Hb 3.5 g/dL) and fetal hydrops; neonatal death due to generalized hydrops 1 ET, 1 TUT Incompatible RBCs (ET), maternal RBCs (TUT)

6 Whang et al. [10], 2000 Third Baby died because of HDFN

Fourth CS in 34th week; three plasma exchange therapies during pregnancy before IUTs; after therapy the infant is alive and in good health 3 IUT, 2 ET Maternal RBCs (IUT), compatible RBCs from relatives (ET)

7 Lenkiewicz and Zupanska [11], 2000 Second Moderate HDFN Phototherapy

8 Deitenbeck et al. [12], 2002 Fifth CS in 34th week 2 IUT, 1 ET, 1 TUT, IVIG Maternal RBCs frozen before pregnancy

9 Brumit et al. [13], 2002 Second Moderate HDFN Phototherapy only

10 Aref et al. [14], 2002 Second Severe anemia (Hb 6 g/dL) and fetal hydrops, CS at 33rd week of pregnancy, resolution of neonatal hydrops after therapy; correction of duodenal atresia 2 ET, IVIG, erythropoietin Compatible thawed RBCs

11 Denomme et al. [15], 2004 Second Delivery at 30th week of pregnancy after premature rupture of membranes; severe anemia (Hb 6 g/dL) and hyperbilirubinemia; baby was discharged from hospital after 1 ET 1 ET Incompatible O RhD-negative RBCs

Third CS due to fetal distress after induction of labor at 38th week of pregnancy; phototherapy was initiated at birth but was discontinued due to low bilirubin levels; follow-up 2 weeks later showed evidence of mild anemia that did not require transfusion 7 IUT, phototherapy Maternal ABO incompatible RBCs

12 Salamat et al. [16], 2004 Fourth CS in 8th month of pregnancy; intrauterine death due to fetal hydrops No

13 Hirose et al. [17], 2004 First; blood transfusion before pregnancy CS in 34th week, severe anemia and hyperbilirubinemia; after therapy the infant is alive and in good health 1 IUT, 2 ET Compatible fresh donor's RBCs

14 Shah et al. [18], 2005 Fourth Delivery in 37th week; after therapy baby is alive and in good health 3 ET, 1 TUT, IVIG Maternal RBCs (1 ET, 1 TUT); incompatible RBCs (2 ET)

15 Li et al. [26], 2010 Second Delivery 39th week; neonatal anemia (Hb 8.1 g/dL), severe hyperbilirubinemia and neonatal hydrops; after therapy the infant is alive and in good health 1 ET, 3 TUT, IVIG, phototherapy, methylprednisolone Incompatible RBCs, donors O RhD-positive phenotype ccEE

HDFN, hemolytic disease of the fetus and newborn; Hb, hemoglobin; IUT, intrauterine transfusion; ET, exchange transfusion; TUT, top-up transfusion; IVIG, intravenous immunoglobulin; CS, cesarean section.